4d Molecular Therapeutics In shares owned by Bridgefront Capital
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Bridgefront Capital
from 13F filings
Historical chart of Bridgefront Capital investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in 4d Molecular Therapeutics In by Bridgefront Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $214k | 10k | 20.99 |